Home | Welcome to Contract Pharma   
Last Updated Tuesday, May 21 2013
Print RSS Feed

Breaking News

Related Searches: Collaborations & Alliances

April 9, 2010
Penwest Pharmaceuticals and Alvogen, Inc. have signed a drug development and commercialization agreement under which the two companies will work to identify and select as many as five compounds for generic development.  Read More »

April 9, 2010
Cephalon, Inc. has completed its acquisition of Mepha, a Swiss-based pharmaceutical company, for approximately $615.4 million.   Read More »

April 8, 2010
ADC drug expected to file in 1H11  Read More »

April 8, 2010
Preclinical diabetes compound at center of deal  Read More »

April 7, 2010
ICON and Tigermed Consulting, a provider of clinical drug development services in China, have signed an alliance agreement.   Read More »

April 7, 2010
Peter Ciano has been appointed vice president of corporate development, Tris Pharma.   Read More »

April 7, 2010
The FDA has approved Purdue Pharma's NDA for a reformulation of OxyContin (oxycodone HCl controlled-release) Tablets.  Read More »

April 6, 2010
Crucell N.V. and GlaxoSmithKline Biologicals have signed an agreement to collaborate on the development of a second-generation malaria vaccine candidate.   Read More »

April 6, 2010
SAFC, a member of the Sigma-Aldrich Group, has opened a $30 million expansion to its Madison manufacturing facility in Verona, WI.  Read More »

April 6, 2010
Daiichi Sankyo has submitted a NDA to the Ministry of Health, Labor and Welfare in Japan seeking approval of edoxaban for the prevention of venous thromboembolism (VTE) after major orthopedic surgery.  Read More »

April 5, 2010
Warner Chilcott and Sanofi-Aventis have amended their Actonel global collaboration agreement regarding the U.S. and Puerto Rico.  Read More »

April 5, 2010
Halozyme Therapeutics and Avid Bioservices have expanded their commercial supply agreements and entered a long-term strategic relationship.  Read More »

April 5, 2010
Celsis Analytical Services has expanded the analytical chemistry capabilities at its CGMP labs to include mass spectrometry (LC-MS/MS) and ion chromatography, in an effort to make it easier to analyze complex materials and compounds.  Read More »

April 1, 2010
Obesity drug showed strong results in trials.  Read More »

April 1, 2010
Ricerca to reach Asian markets with development pact.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On